Aptagen, LLC
HD3S/53 (ID# 9551)
DNA
Htt
Small Organic
77.2°C
NA If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
5'-dGpdCpdTpdGpdTpdTpdGpdCpdTpdGpdCpdTpdGpdTpdTpdGpdTpdTpdGpdCpdTpdGpdTpdTpdGpdCpdApdGpdCpdTpdGpdTpdTpdGpdGpdApdApdGpdGpdApdCpdTpdTpdGpdApdGpdGpdGpdApdCpdTpdCpdGp-3'
53
16479.6 g/mole
486600 L/(mole·cm)
Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
Parekh-Olmedo, H., Wang, J., Gusella, J.F. et al. Modified single-stranded oligonucleotides inhibit aggregate formation and toxicity induced by expanded polyglutamine. J Mol Neurosci 24, 257–267 (2004). https://doi.org/10.1385/JMN:24:2:257
Have your aptamer oligo synthesized ORDER
We are always looking for ways to improve. Please tell us what you think.